Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The UK government has awarded funding to Biocontrol, AmpliPhi Biosciences' wholly owned subsidiary, through the Technology Strategy Board, for research and development using genomics-based technologies.
Subscribe to our email newsletter
As part of the £4.5m, eleven project initiative, this specific project will fund a consortium of five industrial and academic partners led by Unilever.
During the three year program of research, AmpliPhi Biosciences will exploit novel genomic information to develop next generation, specific, natural antimicrobials for use in the personal care industry.
AmpliPhi CEO Edward Cappabianca said they anticipate that the information they gain during the execution of this project will contribute significantly to their knowledge base of how to develop novel antimicrobial products for the general market, and in turn help to advance their development of human therapeutics to treat bacterial infections.